ESBRIET is a prescription medicine for lung disease called idiopathic pulmonary fibrosis (IPF) treatment.
INDICATIONS AND USAGE
ESBRIET is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF).
DOSAGE FORMS & STRENGTHS
• Capsules: 267 mg
• Tablets: 267 mg, 801 mg
Manufactured By: Genentech
Prescribing Information URL: Click Here
South Delhi Pharma can facilitate the supply of “ESBRIET ® (pirfenidone) capsules and film-coated tablets” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis. It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II.
It was first approved in Japan for the treatment of patients with idiopathic pulmonary fibrosis after clinical trials, under the trade name of Pirespa by Shionogi, in 2008. It was approved for use in the European Union in 2011, in Canada in 2012, and in the United States in October 2014. There is also a topical form created for the treatment of abnormal wound healing processes.